Straumann Holding AG (XSWX:STMN) Moat Score: 7/10 (As of Jun. 26, 2026)


XSWX:STMN Straumann Holding AG XSWX:STMN
99 GF Score
Price CHF106.80
GF Value CHF136.92
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Straumann Holding AG Moat Score?

Straumann Holding AG XSWX:STMN +1.81% 99 Moat Score is 7 as of Jun. 26, 2026. GuruFocus rates XSWX:STMN with a GF Score™ of 99/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Straumann Holding AG ranks better than 98.94% on this metric.

Straumann Holding AG has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Straumann Holding AG has Wide Moat: Straumann Holding AG benefits from strong brand strength and customer loyalty in the dental industry, supported by valuable intellectual property and patents. The company has a superior distribution network and significant pricing power due to its market leadership. These factors contribute to a durable competitive advantage, justifying a wide moat classification.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Straumann Holding AG might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Straumann Holding AG  (XSWX:STMN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Straumann Holding AG Moat Score Related Terms

XSWX:STMN vs ISRG, BDX, MDLN: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Straumann Holding AG Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Moat Score distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's Moat Score falls into.


XSWX:STMN
99GF Score
Straumann Holding AG XSWX:STMN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Straumann Holding AG (XSWX:STMN) has a Moat Score of 7 as of Jun. 26, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Straumann Holding AG ranks #9 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is Straumann Holding AG's Moat Score too high?
Straumann Holding AG's current Moat Score is 7. Based on the distribution chart, Straumann Holding AG ranks #9 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Straumann Holding AG has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Moat Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #9 out of 846 companies for Moat Score. This places Straumann Holding AG in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Straumann Holding AG's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.80 — trading 22% below its estimated fair value. The current Moat Score is 7. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Moat Score is 7 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?

Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued. The current stock price of CHF106.80 is trading 22% below its estimated GF Value™ of CHF136.92. GuruFocus considers Straumann Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:STMN:

  • Moat Score: 7
  • GF Value™: CHF136.92 vs. price of CHF106.80 (22% below fair value)
  • GF Score™: 99/100 with 7 warning signs

No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Straumann Holding AG Business Description

Address Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score

Get the complete analysis for XSWX:STMN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF106.80
Price
CHF136.92
GF Value